The study drug is a potential new treatment for asthma.

3 nights
6 visits

Asthma is a widespread chronic respiratory condition characterized by breathing difficulties, airway constriction, mucus buildup, and inflammation.

Despite receiving high-dose treatment, severe asthma patients still struggle to control their symptoms, which greatly impacts their quality of life.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!


Biological Sex Male or Female
Age 18-55 years old
BMI 18 - 32kg/m²
Medical History No significant medical history
Medication Not taking any prescription medication
Smoking History Non-smokers or light smokers (less than 5 cigarettes/week)